SOLACI CongressesSOLACI-SBHCI'19

SOLACI-SBHCI 2019

solaci
solaci
682
0

Here you will find the most relevant articles about the SOLACI-SBHCI 2019 Congress, held on August 1st, 2nd & 3rd at Frei Caneca Convention Center, Sao Paulo, Brazil.

If you cannot view the articles, click here.

Previous article
SOLACI Congress 2019 | Discover the Preliminary Scientific Program
Next article
SOLACI Congress 2019 | Discover the Highlights from SOLACI-SBHCI 2019
solaci
solaci

More articles by this author

SOLACI-SBHCI 23

solaci - 0
Here you will find the most relevant articles about the SOLACI-SBHCI 2023 Congress. If you cannot view the articles, click here.

PCI-Advances in DIABETIC PATIENTS – MIL & WIN SESSION – SOLACI-SOCIME 2022

solaci - 0
✔️ PCI-Advances in DIABETIC PATIENTES - MIL & WIN SESSION ✔️ SOLACI-SOCIME 2022 Scientific Session 👨‍🏫 Contents: 00:10 - Welcoming words - Dra. Emma Miranda (MEX)...

SOLACI-SOCIME 22

solaci - 0
Here you will find the most relevant articles about the SOLACI-SOCIME 2022 Congress. If you cannot view the articles, click here.

SOLACI-CACI 21

solaci - 0
Here you will find the most relevant articles about the SOLACI-CACI 2021 Congress. If you cannot view the articles, click here.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Congresses

SOLACI-SBHCI 23

Here you will find the most relevant articles about the SOLACI-SBHCI 2023 Congress. If you cannot view the articles, click here.
solaci -
SOLACI Sessionsspot_img

Recent Articles

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Dr. Juan Manuel Pérez - 0
Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Dr. Andrés Rodríguez - 0
Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Dr. Omar Tupayachi - 0
Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...